Lamivudine

Product NDC: 65862-552
11-digit product format: 658620552
Labeler code: 65862
Product ID: 65862-552_199cd88b-1136-4ac0-a58d-81ea700ce718
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Lamivudine
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Aurobindo Pharma Limited
Application: ANDA202032
Marketing category: ANDA
Marketing start: 2011-11-17
Marketing end: 0000-00-00
Substance: LAMIVUDINE
Active strength: 150 mg/1
Pharmacologic classes: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	65862-552		D	Discontinued by firm	2026-10-15
excluded package	package	65862-552	65862-552-10	D	Discontinued by firm	2026-10-15
excluded package	package	65862-552	65862-552-60	D	Discontinued by firm	2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Archive	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	excluded / ndc_excluded.zip	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	65862-552-10	D	Discontinued by firm	excluded / ndc_excluded.zip	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	65862-552-60	D	Discontinued by firm	excluded / ndc_excluded.zip	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	excluded / ndc_excluded.zip	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	65862-552-10	D	Discontinued by firm	excluded / ndc_excluded.zip	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	65862-552-60	D	Discontinued by firm	excluded / ndc_excluded.zip	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	excluded / ndc_excluded.zip	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	65862-552-10	D	Discontinued by firm	excluded / ndc_excluded.zip	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	65862-552-60	D	Discontinued by firm	excluded / ndc_excluded.zip	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	excluded / ndc_excluded.zip	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	65862-552-10	D	Discontinued by firm	excluded / ndc_excluded.zip	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	65862-552-60	D	Discontinued by firm	excluded / ndc_excluded.zip	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	excluded / ndc_excluded.zip	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	65862-552-10	D	Discontinued by firm	excluded / ndc_excluded.zip	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	65862-552-60	D	Discontinued by firm	excluded / ndc_excluded.zip	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	excluded / ndc_excluded.zip	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	65862-552-10	D	Discontinued by firm	excluded / ndc_excluded.zip	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	65862-552-60	D	Discontinued by firm	excluded / ndc_excluded.zip	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	excluded / ndc_excluded.zip	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	65862-552-10	D	Discontinued by firm	excluded / ndc_excluded.zip	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	65862-552-60	D	Discontinued by firm	excluded / ndc_excluded.zip	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	excluded / ndc_excluded.zip	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	65862-552-10	D	Discontinued by firm	excluded / ndc_excluded.zip	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	65862-552-60	D	Discontinued by firm	excluded / ndc_excluded.zip	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	excluded / ndc_excluded.zip	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	65862-552-10	D	Discontinued by firm	excluded / ndc_excluded.zip	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	65862-552-60	D	Discontinued by firm	excluded / ndc_excluded.zip	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		D	Discontinued by firm	excluded / ndc_excluded.zip	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	65862-552-10	D	Discontinued by firm	excluded / ndc_excluded.zip	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	65862-552-60	D	Discontinued by firm	excluded / ndc_excluded.zip	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		D	Discontinued by firm	excluded / ndc_excluded.zip	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	65862-552-10	D	Discontinued by firm	excluded / ndc_excluded.zip	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	65862-552-60	D	Discontinued by firm	excluded / ndc_excluded.zip	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		D	Discontinued by firm	excluded / ndc_excluded.zip	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	65862-552-10	D	Discontinued by firm	excluded / ndc_excluded.zip	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	65862-552-60	D	Discontinued by firm	excluded / ndc_excluded.zip	`557ba5c1ecfa…`	`9c80585c8c6e…`
2021-12-27 23:28 UTC · source 2021-12-27	unfinished product	product		UNFINISHED	Active or certified unfinished drug listing	unfinished / ndc_unfinished.zip	`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-12-27 23:28 UTC · source 2021-12-27	unfinished package	package	65862-552-26	UNFINISHED	Active or certified unfinished drug listing	unfinished / ndc_unfinished.zip	`6db9cb8d1e19…`	`3449e1ec5b70…`
2021-02-18 23:40 UTC · source 2021-02-18	unfinished product	product		UNFINISHED	Active or certified unfinished drug listing	unfinished / ndc_unfinished.zip	`8fc7167e32ce…`	`e96bbc724034…`
2021-02-18 23:40 UTC · source 2021-02-18	unfinished package	package	65862-552-26	UNFINISHED	Active or certified unfinished drug listing	unfinished / ndc_unfinished.zip	`8fc7167e32ce…`	`e96bbc724034…`
2020-12-18 03:04 UTC · source 2020-12-17	unfinished product	product		UNFINISHED	Active or certified unfinished drug listing	unfinished / ndc_unfinished.zip	`4184dd79f89f…`	`545327b3e20f…`
2020-12-18 03:04 UTC · source 2020-12-17	unfinished package	package	65862-552-26	UNFINISHED	Active or certified unfinished drug listing	unfinished / ndc_unfinished.zip	`4184dd79f89f…`	`545327b3e20f…`
2020-06-10 20:45 UTC · source 2020-06-10	unfinished product	product		UNFINISHED	Active or certified unfinished drug listing	unfinished / ndc_unfinished.zip	`4bd3596a7b87…`	`5c64c6f6865f…`
2020-06-10 20:45 UTC · source 2020-06-10	unfinished package	package	65862-552-26	UNFINISHED	Active or certified unfinished drug listing	unfinished / ndc_unfinished.zip	`4bd3596a7b87…`	`5c64c6f6865f…`
2019-12-08 06:16 UTC · source 2019-12-05	unfinished product	product		UNFINISHED	Active or certified unfinished drug listing	unfinished / ndc_unfinished.zip	`263afe128892…`	`91768de4ddbe…`
2019-12-08 06:16 UTC · source 2019-12-05	unfinished package	package	65862-552-26	UNFINISHED	Active or certified unfinished drug listing	unfinished / ndc_unfinished.zip	`263afe128892…`	`91768de4ddbe…`
2019-06-01 22:24 UTC · source 2019-05-30	unfinished product	product		UNFINISHED	Active or certified unfinished drug listing	unfinished / ndc_unfinished.zip	`5b2001dcd8f5…`	`54b53d4dc9e4…`
2019-06-01 22:24 UTC · source 2019-05-30	unfinished package	package	65862-552-26	UNFINISHED	Active or certified unfinished drug listing	unfinished / ndc_unfinished.zip	`5b2001dcd8f5…`	`54b53d4dc9e4…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A202032-001	LAMIVUDINE	LAMIVUDINE	150MG	TABLET / ORAL			2011-11-17
A202032-002	LAMIVUDINE	LAMIVUDINE	300MG	TABLET / ORAL			2011-11-17

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 88 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL		2011-11-17	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL		2011-11-17	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL		2011-11-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL		2011-11-17	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL		2011-11-17	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL		2011-11-17	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL		2011-11-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL		2011-11-17	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL		2011-11-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL		2011-11-17	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL		2011-11-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL		2011-11-17	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL		2011-11-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL		2011-11-17	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL		2011-11-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL		2011-11-17	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL		2011-11-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL		2011-11-17	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL		2011-11-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL		2011-11-17	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL		2011-11-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL		2011-11-17	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL		2011-11-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL		2011-11-17	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL		2011-11-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL		2011-11-17	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL		2011-11-17	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL		2011-11-17	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL		2011-11-17	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL		2011-11-17	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL		2011-11-17	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL		2011-11-17	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL		2011-11-17	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL		2011-11-17	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL		2011-11-17	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL		2011-11-17	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL		2011-11-17	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL		2011-11-17	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A202032-001	LAMIVUDINE	150MG	TABLET / ORAL	AB	2011-11-17	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A202032-002	LAMIVUDINE	300MG	TABLET / ORAL	AB	2011-11-17	`4b0b4de00fa7…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-04-04 05:41 UTC	2022-04	A202032-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A202032-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A202032-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A202032-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A202032-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A202032-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A202032-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A202032-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A202032-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A202032-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A202032-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A202032-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A202032-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A202032-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A202032-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A202032-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A202032-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A202032-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A202032-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A202032-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A202032-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A202032-002	AB	1	`ea99ee380514…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
65862-552-60	EA - Each	65862-552	5c296034-e20b-42ec-ad6c-165fc42b2cbe	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	4
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	LAMIVUDINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	4
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LAMIVUDINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	4
HYPROMELLOSE 2910 (5 MPA.S)	INACTIVE INGREDIENT	R75537T0T4	LAMIVUDINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LAMIVUDINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	4
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	LAMIVUDINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	4
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	LAMIVUDINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	4
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	LAMIVUDINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	4
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LAMIVUDINE TABLET, FILM COATED [AUROBINDO PHARMA LIMITED]	4

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
2T8Q726O95	LAMIVUDINE	134678-17-4	LAMIVUDINE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
65862-552-10	65862055210	6 BLISTER PACK in 1 CARTON (65862-552-10) > 10 TABLET, FILM COATED in 1 BLISTER PACK	6 blister pack	2011-11-17	0000-00-00	No	No	Current
65862-552-60	65862055260	60 TABLET, FILM COATED in 1 BOTTLE (65862-552-60)		2011-11-17	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Lamivudine	Aurobindo Pharma Limited	2019-09-11	Human Prescription Drug Label	10
Lamivudine	REMEDYREPACK INC.	2019-06-07	HUMAN PRESCRIPTION DRUG LABEL	3